KDM6B regulates M2 polarization of macrophages by modulating the stability of nuclear β-catenin

Accumulating evidences suggests that the epigenetic regulation play a pivotal role in establishing phenotype and function of tumor associated macrophages (TAMs). KDM6B is an epigenetic Enzyme responsible for the H3K27me3 and reported to influence macrophage polarization. However, the underlying mechanism remains to be determined. Here, we demonstrated that inhibition of KDM6B in TAMs increased M2 polarization induced by coculture of breast Cancer cells. Furthermore, we identified that KDM6B downregulation activated β-catenin/c-Myc signaling, and thus promotes the M2-like phenotype. KDM6B accelerated the intranuclear ubiquitination degradation of β-catenin, which depends on its demethylase activity. Therapeutically, our data showed that activated vitamin D analog paricalcitol upregulated the expression of KDM6B and decreases the M2 polarization, consequently protected against tumor progress in the xenograft mouse model of breast Cancer. Taken together, our data reveal that epigenetic regulator KDM6B prevents M2 polarization via promoting the intranuclear degradation of β-catenin. Active vitamin D analog induces KDM6B and suppresses tumor progress, suggesting a novel therapeutic potential of epigenetic modulation for the tumor treatment.

KDM6B; M2 polarization; Paricalcitol; Tumor-associated macrophages; β-Catenin.